ONE‑D is a breakthrough single‑day TMS protocol that delivers a full therapeutic course in just one visit. Built for people who need effective relief without the weeks of traditional sessions, it blends high‑dose TMS with smart neuroplasticity support.
Outcomes remained strong across measures (e.g., HDRS‑17: ~92.6% response, ~77.8% remission) (breakthrupsych.com, stimulatingbrains.org)
All participants completed the session with no serious adverse events; mild scalp discomfort reported (mean 5.8/10) (stimulatingbrains.org)
These figures significantly outperform standard TMS remission rates (~30–35%) and condensed accelerated protocols (Patient Care Online).
Consider ONE‑D if you:
Note: The protocol uses off-label medications (D‑cycloserine and Vyvanse) and, in many clinics, is self‑pay only—typically not covered by insurance (breakthrupsych.com, clearpathpsychiatry.com).
"*" indicates required fields